Kannalife, Inc. to Present Breakthrough CIPN Study Findings on the Comparison of KLS-13019 to CBD at 29th Annual International Cannabinoid Research Society Conference
DOYLESTOWN, Pa., June 27, 2019 (GLOBE NEWSWIRE) — Kannalife, Inc. (OTC: KLFE) (“Kannalife” or “the Company”), a biopharmaceutical company focused on the research, development and discovery of natural and novel biomimetic cannabinoid therapeutic agents, announced today that Douglas Brenneman, PhD, will present […]